GOLGA2/GM130, cis-Golgi matrix protein, is a novel target of anticancer gene therapy.
Chang SH, Hong SH, Jiang HL, Minai-Tehrani A, Yu KN, Lee JH, Kim JE, Shin JY, Kang B, Park S, Han K, Chae C, Cho MH.
Chang SH, et al. Among authors: lee jh.
Mol Ther. 2012 Nov;20(11):2052-63. doi: 10.1038/mt.2012.125. Epub 2012 Jun 26.
Mol Ther. 2012.
PMID: 22735382
Free PMC article.